- Massive Demand & Disruptive Potential – Boxabl has received interest for over 190,000 homes, positioning itself as a major disruptor in the housing market.
- Revolutionary Manufacturing Approach – Inspired by Henry Ford’s assembly line, Boxabl’s foldable tiny homes are designed for high-efficiency production, making homeownership more accessible.
- Affordable Investment Opportunity – With homes priced at $60,000, Boxabl is raising $1 billion to scale production, offering investors a chance to own a stake in its growth.
Gainers
- Motus GI Hldgs MOTS stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7 million.
- Arcutis Biotherapeutics ARQT stock rose 8.67% to $33.2. The company's market cap stands at $1.6 billion.
- AnPac Bio-Medical Science ANPC shares rose 8.22% to $5.92. The market value of their outstanding shares is at $66.3 million. As per the news, the Q4 earnings report came out today.
- Cyclacel Pharmaceuticals CYCC shares moved upwards by 6.75% to $7.59. The market value of their outstanding shares is at $69.6 million.
- DBV Technologies DBVT shares moved upwards by 5.67% to $6.7. The company's market cap stands at $736.1 million.
- Obalon Therapeutics OBLN shares rose 4.96% to $2.75. The market value of their outstanding shares is at $27.5 million.
Losers
- Ardelyx ARDX shares decreased by 18.75% to $6.85 during Friday's pre-market session. The market value of their outstanding shares is at $675.9 million.
- Pluristem Therapeutics PSTI stock decreased by 6.72% to $4.03. The company's market cap stands at $127.9 million.
- Marker Therapeutics MRKR stock declined by 5.97% to $2.52. The market value of their outstanding shares is at $209.2 million.
- Pacific Biosciences PACB shares declined by 5.92% to $31.5. The company's market cap stands at $6.0 billion. The company's, Q1 earnings came out yesterday.
- Osmotica Pharmaceuticals OSMT stock decreased by 5.39% to $2.81. The company's market cap stands at $176.2 million.
- ResMed RMD shares fell 4.53% to $198.5. The market value of their outstanding shares is at $28.8 billion. As per the press release, Q3 earnings came out yesterday.
ARDXArdelyx Inc
$3.852.43%
Edge Rankings
Momentum
11.92
Growth
Not Available
Quality
Not Available
Value
58.52
Price Trend
Short
Medium
Long
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in